Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pietzcker

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Schizophrenia Bulletin|January 1, 1987
Prospective study of course of illness in schizophrenia: Part III. Treatment and outcomeW Gaebel, A Pietzcker
European Archives of Psychiatry and Neurological Sciences|January 1, 1985
Multidimensional study of the outcome of schizophrenic patients 1 year after clinic discharge. Predictors and influence of neuroleptic treatmentW Gaebel, A Pietzcker
Der Nervenarzt|September 1, 1983
[Indications for long-term neuroleptic medication--standard procedure or individual prognosis-guided intervention? A prospective study of the clinical treatment model]W Gaebel, A Pietzcker
Acta Psychiatrica Scandinavica|July 6, 2017
Depressive Syndromes and Scales in the AMDP-systemA Pietzcker, R Gebhardt
Schizophrenia Bulletin|January 1, 1987
Prospective study of course of illness in schizophrenia: Part II. Prediction of outcomeW Gaebel, A Pietzcker
European Archives of Psychiatry and Neurological Sciences|January 1, 1985
Sex differences in the psychopathology of inpatientsR Gebhardt, A Pietzcker
Pharmacopsychiatry|May 1, 1985
One-year outcome of schizophrenic patients--the interaction of chronicity and neuroleptic treatmentW Gaebel, A Pietzcker
European Archives of Psychiatry and Neurological Sciences|January 1, 1984
Prognosis of the course of schizophrenic psychoses compared to other psychiatric illnesses. Catamnestic treatment and outcome 1 year after dischargeW Gaebel, A Pietzcker
Pharmacopsychiatria|November 1, 1983
Prediction of "natural" course, relapse and prophylactic response in schizophrenic patientsA Pietzcker, W Gaebel
Pharmacopsychiatry|September 1, 1984
The outpatient clinic for patients under chronic lithium or neuroleptic treatment as a phase-IV research toolA Pietzcker, B Müller-Oerlinghausen
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Schizophrenia Bulletin|January 1, 1987
Prospective study of course of illness in schizophrenia: Part III. Treatment and outcomeW Gaebel, A Pietzcker
European Archives of Psychiatry and Neurological Sciences|January 1, 1985
Multidimensional study of the outcome of schizophrenic patients 1 year after clinic discharge. Predictors and influence of neuroleptic treatmentW Gaebel, A Pietzcker
Der Nervenarzt|September 1, 1983
[Indications for long-term neuroleptic medication--standard procedure or individual prognosis-guided intervention? A prospective study of the clinical treatment model]W Gaebel, A Pietzcker
Acta Psychiatrica Scandinavica|July 6, 2017
Depressive Syndromes and Scales in the AMDP-systemA Pietzcker, R Gebhardt
Schizophrenia Bulletin|January 1, 1987
Prospective study of course of illness in schizophrenia: Part II. Prediction of outcomeW Gaebel, A Pietzcker
European Archives of Psychiatry and Neurological Sciences|January 1, 1985
Sex differences in the psychopathology of inpatientsR Gebhardt, A Pietzcker
Pharmacopsychiatry|May 1, 1985
One-year outcome of schizophrenic patients--the interaction of chronicity and neuroleptic treatmentW Gaebel, A Pietzcker
European Archives of Psychiatry and Neurological Sciences|January 1, 1984
Prognosis of the course of schizophrenic psychoses compared to other psychiatric illnesses. Catamnestic treatment and outcome 1 year after dischargeW Gaebel, A Pietzcker
Pharmacopsychiatria|November 1, 1983
Prediction of "natural" course, relapse and prophylactic response in schizophrenic patientsA Pietzcker, W Gaebel
Pharmacopsychiatry|September 1, 1984
The outpatient clinic for patients under chronic lithium or neuroleptic treatment as a phase-IV research toolA Pietzcker, B Müller-Oerlinghausen
Pageof 5